Active · per the CBE, 30 October 2026

FINANCIA PHARMA

BE0832300679

Rechtspersoon Private limited company 1 establishment

FINANCIA PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 29 December 2010, 1 establishment.

Rue de la Chapelle 35, 1360 Perwez

Behind the company: Pierre ANCIA.

Active for

15 year, 10 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.

  • Figures corrected NBB

    Corrected annual account filed for 2022.

Financials

Financial year 2025

FINANCIA PHARMA from Perwez, company number BE0832300679, closed financial year 2025 with a result of € 171,565 after tax. For that financial year FINANCIA PHARMA recorded a gross margin of € 234,929 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 155,216 to € 171,565. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 1.7 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 171,565

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,415

▲ 64% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.7 million.

Debts at end 2025

Bank debt ≈ 2 years to go

€ 260,300

▼ 32% vs 2024

€ 116,978 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 5,252

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,172

▼ 71% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 202,735 € 211,502 € 215,419 € 234,929 ▲ 9%
Profit after taxes € 142,862 € 149,883 € 155,216 € 171,565 ▲ 11%
Equity € 1,264,565 € 1,414,448 € 1,569,664 € 1,741,229 ▲ 11%
Total debts € 1,520,241 € 1,573,693 € 1,149,080 € 1,078,508 ▼ 6%
Cash € 7,135 € 11,451 € 4,527 € 7,415 ▲ 64%
Retained profit € 1,245,965 € 1,395,848 € 1,551,064 € 1,722,629 ▲ 11%
Bank debt € 610,044 € 487,819 € 380,108 € 260,300 ▼ 32%
Balance sheet total € 2,784,806 € 2,988,141 € 2,718,744 € 2,819,737 ▲ 4%

Key figures of FINANCIA PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to FINANCIA PHARMA?

What happened at FINANCIA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 171,565 (▲ 11% vs 2024). Source: NBB ↗
  • New establishment in Perwez. KBO
  • Start of the company according to the CBE. KBO

In short

From € 142,862 profit in 2022 to € 171,565 profit in 2025.

Paid € 214,175 in corporate taxes since 2022.

Best year ever: 2025, with € 171,565 profit.

Original PDFs at the National Bank ↗

Management

Pierre ANCIA
FINANCIA PHARMA
PHARMACIE DE LA CHAPELLE
LOUVIMAR
KI LAIT CRU
+1

Behind FINANCIA PHARMA is Pierre ANCIA. Pierre ANCIA is also behind PHARMACIE DE LA CHAPELLE, LOUVIMAR, KI LAIT CRU and Pharmacie de la Linière.

Directors

According to the 2025 annual accounts

Pierre ANCIA

Director

Also active at: PHARMACIE DE LA CHAPELLE, LOUVIMAR, KI LAIT CRU, Pharmacie de la Linière

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Chapelle 35

1360 Perwez

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

PHARMACIE DE LA CHAPELLE same network

€ 534,442 gross margin · 2025

LOUVIMAR same network

€ 281,156 gross margin · 2025

Pharmacie de la Linière same network

€ 434,752 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0832.300.679
VAT number
BE 0832.300.679
Registered office
Rue de la Chapelle 35, 1360 Perwez
Names & denominations
FINANCIA PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
29 December 2010
Peppol
Active · Active since 16 Dec 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does FINANCIA PHARMA do?
FINANCIA PHARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 29 December 2010, 1 establishment.
What is the address of FINANCIA PHARMA?
The registered office of FINANCIA PHARMA is located at Rue de la Chapelle 35, 1360 Perwez.
Is FINANCIA PHARMA still active?
Yes. According to the CBE (30 October 2026) FINANCIA PHARMA is active, legal situation “Normale toestand”, started on 29 December 2010.
Is FINANCIA PHARMA registered on Peppol?
Yes, FINANCIA PHARMA is registered on the Peppol network with ID 0208:0832300679.
What is the enterprise number of FINANCIA PHARMA?
The enterprise number of FINANCIA PHARMA is BE0832300679.
When was FINANCIA PHARMA founded?
FINANCIA PHARMA was founded on 29 December 2010.